IMHDPA-4-OH
IMHDPA-4-OH is an mTORC1 inhibitor and autophagy inducer. IMHDPA-4-OH inhibits mTORC1 signaling and reduces p70S6K and p4EBP1 phosphorylation, thereby relieving the autophagy blockade. IMHDPA-4-OH interferes with cholesterol metabolism and induces cell cycle arrest at G0. IMHDPA-4-OH can be used for research on cervical cancer.
For research use only. We do not sell to patients.
- CAS No.: 3105699-76-8
- Formula: C17H20N6O
- Molecular Weight:324.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | GI50 |
2.96 nM
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
42571760 |
In Vitro
IMHDPA-4-OH (Compound 39) (72 h) exhibits potent antiproliferative activity against HeLa cells with a GI50 of 2.96 nM[1].
IMHDPA-4-OH (5-20 nM; two weeks) suppresses clonogenic growth of HeLa cells in a dose-dependent manner[1].
IMHDPA-4-OH (20-40 nM; 24 h) inhibits the migration and invasion of HeLa cells[1].
IMHDPA-4-OH (80 nM; 12 days) suppresses the growth of 3D HeLa tumor spheroids[1].
IMHDPA-4-OH (20 nM; 48 h) induces weak senescence characteristics in HeLa cells[1].
IMHDPA-4-OH (20-80 nM) modulates the expression of senescence hallmark proteins in HeLa cells[1].
IMHDPA-4-OH (40 nM; 48 h) induces the formation of autophagosomes in HeLa cells[1].
IMHDPA-4-OH (20-80 nM) decreases cleaved PARP and activates autophagy in HeLa cells[1].
IMHDPA-4-OH (20-80 nM) inhibits mTORC1 signaling in HeLa cells[1].
IMHDPA-4-OH (10-40 nM; 12-48 h) induces cell cycle arrest in the G0/G1 phase in a time- and dose-dependent manner in HeLa cells[1].
IMHDPA-4-OH (10-40 nM; 12-48 h) increases the proportion of Annexin V-positive HeLa cells in a time- and dose-dependent manner[1].
IMHDPA-4-OH (2 μM; 12 h) does not induce ROS accumulation in HeLa cells[1].
IMHDPA-4-OH (20-80 nM; 48 h) induces bulk macroautophagy, rather than selective mitophagy, in HeLa cells[1].
IMHDPA-4-OH (20 nM; 48 h) disrupts cholesterol metabolism in HeLa cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HeLa
-
Concentration:5 nM; 10 nM; 20 nM
-
Incubation Time:two weeks
-
Result:Resulted in a dose-dependent reduction in both colony number and size compared to control cells.
-
Cell Line:HeLa
-
Concentration:20 nM; 40 nM
-
Incubation Time:24 h
-
Result:Reduced the migration and invasion abilities of HeLa cells, as the quantity of cells migrating across the transwell or invading the Matrigel-coated filter significantly decreased compared to controls.
-
Cell Line:HeLa
-
Concentration:10-40 nM (dose-dependence); 20 nM (time-course)
-
Incubation Time:24 h (dose-dependence); 12-48 h (time-course)
-
Result:Increased the proportion of cells in the G0/G1 phase to 65.17%, 70.81%, and 77.25% at 10, 20, and 40 nM respectively, compared to 59.45% in the non-treated group.
Prolonging treatment with 20 nM increased G0/G1 phase cells to 73.73%, 80.56%, and 84.34% at 12, 24, and 48 h, compared to 65.64% at 0 h.
-
Cell Line:HeLa
-
Concentration:10-40 nM (dose-dependence); 20 nM (time-course)
-
Incubation Time:24 h (dose-dependence); 12-48 h (time-course)
-
Result:The proportion of Annexin V-positive cells increased from 8.52% in the control group to 13.15%, 32.7%, and 48.5% following treatment with 10, 20, and 40 nM IMHDPA-4-OH, respectively.
Prolonging treatment with 20 nM increased the percentage of Annexin V-positive cells from 8.54% to 13.03%, 25.34%, and 58.4% after 12, 24, and 48 h, respectively.
-
Cell Line:HeLa
-
Concentration:20 nM; 40 nM; 80 nM
-
Incubation Time:48 h
-
Result:Showed a dose-dependent reduction in p62.
Neither TOM20 nor COX IV exhibited appreciable changes following IMHDPA-4-OH treatment.
Chemical Information
-
CAS No. 3105699-76-8
-
Molecular Weight 324.38
-
Formula C17H20N6O
-
SMILES
OC1=CC=CC2=C1C(/C=N/NC3=NC=NC(N(CC)CC)=C3)=CN2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)